Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 592 clinical trials
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

This phase II trial studies the side effects and how well combination chemotherapy and nelarabine work in treating patients with T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma

combination chemotherapy
methotrexate
cytarabine
cancer
prednisone
  • 29 views
  • 30 Jun, 2022
  • 1 location
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)

This study will help researchers collect more information about how effective the combination of venetoclax and obinutuzumab is in treating CLL in people who have not received a previous treatment for their cancer.

chronic lymphocytic leukemia
cancer
venetoclax
neutrophil count
obinutuzumab
  • 0 views
  • 09 Jun, 2022
  • 6 locations
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO)

This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab -- as a possible treatment for chronic lymphocytic leukemia (CLL). The drugs

fever
chronic lymphocytic leukemia
venetoclax
lymphadenopathy
neutrophil count
  • 233 views
  • 19 Jun, 2022
  • 3 locations
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Background The drug venetoclax treats chronic lymphocytic leukemia (CLL). Researchers want to find better treatments for CLL. To do that, they need to learn how

chronic lymphocytic leukemia
fever
cancer
venetoclax
lymphadenopathy
  • 0 views
  • 27 Jun, 2022
  • 1 location
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

patients with acute myeloid leukemia and high-grade myeloid neoplasms. Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Chemotherapy drugs, such

ejection fraction
cladribine
gilbert's syndrome
cancer
venetoclax
  • 0 views
  • 13 May, 2022
  • 1 location
Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

20 mg or 40 mg of quizartinib will be given to Chinese patients who were just diagnosed with AML. The study drug will be given to them along with standard therapies. The purpose is to find out the highest dose they can stand.

cytarabine
  • 8 views
  • 25 Apr, 2022
  • 1 location
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)

when given in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of

ejection fraction
carbon monoxide
induction chemotherapy
decitabine
venetoclax
  • 0 views
  • 28 Apr, 2022
  • 10 locations
Lintuzumab-Ac225 in Combination With Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia

chemotherapy in the management of relapsed/refractory acute myeloid leukemia. This study uses a 3+3 design with a five-patient cohort at the recommended phase 2 dose.

ejection fraction
cladribine
cytarabine
refractory acute myeloid leukemia (aml)
granulocyte colony stimulating factor
  • 14 views
  • 05 May, 2022
  • 1 location
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

This study includes patients with relapsed acute leukemia who have previously been treated with standard treatment that is still present and there is no curative treatment option available

fludarabine
cancer
refractory acute myeloid leukemia (aml)
acute leukemia
hla-a
  • 3 views
  • 15 May, 2022
  • 1 location
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

Rencent years have witnessed great progress of the treatment of acute myeloid leukemia. However, most patients have poor outcomes following the currently first-line DA(daunorubicin, cytarabine

cytarabine
azacitidine
granulocyte colony stimulating factor
colony stimulating factor
idarubicin
  • 0 views
  • 15 May, 2022
  • 1 location